Clinical Trials on Bladder Oversensitivity in South Africa
Total 238 results
-
BayerCompletedOveractive BladderSouth Africa
-
AllerganCompletedOveractive BladderPortugal, South Africa, Netherlands, Canada, Singapore, Brazil, United States, Taiwan, Italy, United Kingdom, France, Spain
-
Hellenic GenitoUrinary Cancer GroupActive, not recruiting
-
Hellenic GenitoUrinary Cancer GroupRecruiting
-
National and Kapodistrian University of AthensCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedIdiopathic Overactive BladderUnited Kingdom
-
Asieris Pharmaceuticals (AUS) Pty Ltd.Completed
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Asieris Pharmaceutical Technologies Co., Ltd.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
Medical University of South CarolinaTerminatedBladder CancerUnited States
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
White River Junction Veterans Affairs Medical CenterMedical University of South Carolina; National Cancer Institute (NCI); University...RecruitingNon-muscle-invasive Bladder CancerUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
AllerganTerminatedUrinary Incontinence | Urinary Bladder | OveractiveUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
-
Vaxiion TherapeuticsCompletedUrothelial Carcinoma of the Urinary BladderUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
Medical University of South CarolinaTerminated
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
Telormedix SACompletedCarcinoma in Situ | Non Muscle Invasive Bladder CancerUnited States
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Christopher Sweeney, MBBSEli Lilly and Company; Genentech, Inc.; Hoosier Cancer Research Network; Walther...CompletedBladder CancerUnited States
-
National Cancer Institute (NCI)TerminatedBladder Carcinoma | Recurrent Bladder CarcinomaUnited States
-
Trans Tasman Radiation Oncology GroupCompletedBladder CancerAustralia, New Zealand
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaActive, not recruitingBladder CancerAustralia
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Institute of Cancer Research, United KingdomTrans Tasman Radiation Oncology GroupActive, not recruitingBladder CancerUnited Kingdom, New Zealand, Australia
-
Predictive BiosciencesCompletedBladder Cancer RecurrenceUnited States
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia